Stay active, stay informed, and keep pushing your limits
Novo Nordisk, Eli Lilly cut GLP-1 drug costs under Medicare Kimberly Redmond 7, 2025// The basics: Novo Nordisk, Eli Lilly cut Medicare and Medicaid costs for GLP-1 drugs Monthly out-of-pocket costs may drop to $50$350, depending on coverage Drugs include Ozempic, Wegovy, Mounjaro, and Zepbound Companies gain three-year tariff exemptions in exchange for lower prices Novo Nordisk and Eli Lilly have struck deals with the federal government
Nadolsky suggests asking your doctor these questions: Based on my age and health, whats the probability that this medicine will improve my well-being, physical functioning, and quality of life
The association between metformin treatment and outcomes in type 2 diabetes mellitus patients with heart failure with preserved ejection fraction: a retrospective study
The FDA has issued multiple rounds of warning letters to telehealth companies marketing compounded GLP-1 products
Separate ethics approval for the current study was not obtained, as it was a post hoc analysis
.jpg)
